BDBM577013 3-(5-cyclopropyl-4-(pyrazin-2- yl)isoxazol-3-yl)-1-isopropyl- 1H-pyrazolo[4,3-c]pyridin-4- amine::US11472802, Example 24

SMILES CC(C)n1nc(-c2noc(C3CC3)c2-c2cnccn2)c2c(N)nccc12

InChI Key InChIKey=GGWWOVLUIBNRKU-UHFFFAOYSA-N

Data  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 577013   

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Array Biopharma

US Patent
LigandPNGBDBM577013(3-(5-cyclopropyl-4-(pyrazin-2- yl)isoxazol-3-yl)-1...)
Affinity DataIC50: 2.30nMAssay Description:The potency of compounds inhibiting several different RET kinase forms (Wild Type, V804M, M918T, G810R, & G810S) were determined using CisBio's H...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577013(3-(5-cyclopropyl-4-(pyrazin-2- yl)isoxazol-3-yl)-1...)
Affinity DataIC50: 15.7nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577013(3-(5-cyclopropyl-4-(pyrazin-2- yl)isoxazol-3-yl)-1...)
Affinity DataIC50: 1.80nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577013(3-(5-cyclopropyl-4-(pyrazin-2- yl)isoxazol-3-yl)-1...)
Affinity DataIC50: 12nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577013(3-(5-cyclopropyl-4-(pyrazin-2- yl)isoxazol-3-yl)-1...)
Affinity DataIC50: 6.90nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent